Nov 21, 2016 12:05 pm UTC| Business
- Second Phase 2 study of lead anti-infective candidate MAT2203 - – On track to report Phase 2 topline data for MAT2203 in the first half of 2017 – BEDMINSTER, N.J., Nov. 21, 2016 -- Matinas BioPharma Holdings,...
Evogene Reports Third Quarter 2016 Financial Results
Nov 21, 2016 12:00 pm UTC| Business
REHOVOT, Israel, Nov. 21, 2016 -- Evogene Ltd. (NYSE:EVGN) (TASE:EVGN), a leading company for the improvement of crop productivity and economics for the food, feed and fuel industries, announced today its financial...
Nov 21, 2016 12:00 pm UTC| Business
The poster, to be presented at the upcoming EORTC-NCI-AACR Molecular Targets and Cancer Therapeutics Symposium, describes results from non-clinical studies conducted by Apogee Biotechnology Corp. demonstrating the...
Nov 21, 2016 12:00 pm UTC| Business
GREENWICH, CT, Nov. 21, 2016 -- Fifth Street Asset Management Inc. (NASDAQ:FSAM) (“FSAM”) announced today that it has rescheduled its earnings release for the quarter ended September 30, 2016 after the financial markets...
Archrock Partners Completes Acquisition of Compression Assets From Archrock, Inc.
Nov 21, 2016 12:00 pm UTC| Business
HOUSTON, Nov. 21, 2016 -- Archrock, Inc. (NYSE:AROC) and Archrock Partners, L.P. (NASDAQ:APLP) today announced that Archrock Partners has completed its previously announced acquisition of compression assets from...
Actinium Pharmaceuticals to Present at LD Micro Main Event Investor Conference
Nov 21, 2016 12:00 pm UTC| Business
NEW YORK, Nov. 21, 2016 -- Actinium Pharmaceuticals, Inc. (NYSE MKT:ATNM) ("Actinium" or "the Company"), a biopharmaceutical Company developing innovative targeted payload immunotherapeutics for the treatment of...
Sera Prognostics to Present at 28th Annual Piper Jaffray Healthcare Conference
Nov 21, 2016 12:00 pm UTC| Business
SALT LAKE CITY, Nov. 21, 2016 -- Sera Prognostics, Inc., a women’s healthcare company, today announced that Gregory C. Critchfield, M.D., M.S., Chairman and Chief Executive Officer, will present at the upcoming 28th...